Profile
Christine Guillen is the founder and currently serves as the Chief Executive Officer & Director of ElsaLys Biotech SAS, a company she founded in 2013.
Prior to founding ElsaLys Biotech SAS, she held the position of Director-Project Management at EUSA Pharma SAS from 2005 to 2007 and Head-External Programs at Transgene SA from 2007 to 2013.
Former positions of Christine Guillen
| Companies | Position | End |
|---|---|---|
| ELSALYS BIOTECH | Founder | - |
| TRANSGENE | Corporate Officer/Principal | 31/12/2012 |
EUSA Pharma SAS
EUSA Pharma SAS BiotechnologyHealth Technology Specializes in pharmaceutical research for rare diseases | Corporate Officer/Principal | 30/09/2007 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Transgene SA
Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
EUSA Pharma SAS
EUSA Pharma SAS BiotechnologyHealth Technology Specializes in pharmaceutical research for rare diseases | Health Technology |
ElsaLys Biotech SAS
ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology Designs, develops and supplies antibodies to modulate the immune system of patients | Health Technology |
- Stock Market
- Insiders
- Christine Guillen
















